Market closedNon-fractional

Cidara Therapeutics/CDTX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Cidara Therapeutics

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Ticker

CDTX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

San Diego, United States

Employees

69

CDTX Metrics

BasicAdvanced
$55M
Market cap
-
P/E ratio
-$8.02
EPS
1.11
Beta
-
Dividend rate
$55M
1.11
0.716
0.555
-17.902
-26.136
-35.29%
-800.93%
1.178
-2.82
-2.82
-2.928
-44.56%
124.97%
57.04%
-38.66%

What the Analysts think about CDTX

Analyst Ratings

Majority rating from 5 analysts.
Buy

CDTX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-122.61% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$8.4M
-52.00%
Net income
-$10M
83.93%
Profit margin
-122.61%
283.16%

CDTX Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 1,040.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$2.80
-$1.80
-$0.80
-$2.28
-
Expected
-$2.60
-$3.25
-$2.07
-$0.20
-$4.10
Surprise
7.69%
-44.62%
-61.29%
1,040.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Cidara Therapeutics stock?

Cidara Therapeutics (CDTX) has a market cap of $55M as of July 06, 2024.

What is the P/E ratio for Cidara Therapeutics stock?

The price to earnings (P/E) ratio for Cidara Therapeutics (CDTX) stock is 0 as of July 06, 2024.

Does Cidara Therapeutics stock pay dividends?

No, Cidara Therapeutics (CDTX) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Cidara Therapeutics dividend payment date?

Cidara Therapeutics (CDTX) stock does not pay dividends to its shareholders.

What is the beta indicator for Cidara Therapeutics?

Cidara Therapeutics (CDTX) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Cidara Therapeutics stock

Buy or sell Cidara Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing